Tolerance of haemodialysis: A randomized cross-over trial of 5-h versus 4-h treatment time

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 8, 1996, Pages 46-51

  Brunet, P ^a   Saingra, Y ^a   Leonetti, F ^a   Vacher Coponat, H ^a   Ramananarivo, P ^a   Berland, Y ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Adverse effects; Chronic haemodialysis patients; Crossover study; Duration of haemodialysis sessions; Hypotension; Tolerance of haemodialysis

Indexed keywords

ADULT; AGED; BACKACHE; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; FEMALE; HEADACHE; HEMODIALYSIS; HUMAN; MALE; MORBIDITY; MORTALITY; NAUSEA; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL;

EID: 0030462284     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp8.46     Document Type: Conference Paper

References (28)

1. Henrich, WL. Hemodynamic instability during hemodialysis. Kidney Int 1986; 30: 605-612
2. Henrich WL. Dialysis considerations in the elderly patient. Am J Kidney Dis 1990; 16: 339-341
3. Sherman RA. The pathophysiologic basis for hemodialysis-related hypotension. Semin Dial 1988; 1: 136-142
4. Shideman JR, Buselmeier TJ, Kjellstrand CM. Hemodialysis in diabetics. Complications in insulin dependents accepted for renal transplantation. Arch Intern Med 1976; 136: 1126-1130
5. Ghent S, Judson MA, Rosansky SJ. Refractory hypotension associated with hypocalcemia and renal disease. Am J Kidney Dis 1994; 23: 430-432
6. Graefe U, Milutinovich J, Folette WC, Wizzo JE, Babb AL, Scribner BH. Less dialysis-induced morbidity and vascular instability with bicarbonate in dialysate. Ann Intern Med 1978; 88: 332-336
7. Vreman HJ, Assomull VM, Kaiser BA, Blaschke TF, Weiner MW. Acetate metabolism and acid-base homeostasis during hemodialysis: influence of dialyzer efficiency and rate of acetate metabolism. Kidney Int Suppl 1980; [Suppl 10]: S62-S74
8. Leunissen KM, Cheriex EC, Janssen J et al. Influence of left ventricular function on changes in plasma volume during acetate and bicarbonate dialysis. Nephrol Dial Transplant 1987; 2: 99-103
9. Lonnemann G, Behme TC, Lenzner B et al. Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria. Kidney Int 1992; 42: 61-68
10. Haeffner-Cavaillon N, Cavaillon JM, Cancioni C, Bade F, Delons S, Kazatchkine MD. In vivo induction of interleukin-1 during hemodialysis. Kidney Int 1989; 35: 1212-1218
11. Sadowski RH, Allred EN, Jabs K. Sodium modeling ameliorates intradialytic and interdialytic symptoms in young hemodialysis patients. J Am Soc Nephrol 1993; 4: 1192-1198
12. Hakim RM, Breillatt J, Lazarus JM, Port FK. Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984; 311: 878-882
13. Cheug AK. Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1990; 1: 150-161
14. Daugirdas JT. Preventing and managing hypotension. Semin Dial 1994; 7: 276-283
15. Sherman RA, Rubin MP, Cody RP, Eisinger RP. Amelioration of hemodialysis-associated hypotension by the use of cool dialysate. Am J Kidney Dis 1985; 5: 124-127
16. Parker TF, Husni L, Huang W, Lew N, Lowrie EG. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994; 23: 670-680
17. Hakim RM, Breyer J, Ismail N, Schulmann G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23: 661-669
18. Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH. Mortality and duration of hemodialysis treatment. JAMA 1991; 265: 871-875
19. Valderrábano F. Weekly duration of dialysis treatment-does it matter for survival? Nephrol Dial Transplant 1996; 11: 569-572
20. Charra B, Calemard E, Ruffet M et al. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286-1291
21. Dumler F, Stalla K, Mohini R, Zasuwa G, Levin NW. Clinical experience with short-time hemodialysis. Am J Kidney Dis 1992; 19: 49-56
22. Orofino L, Marcen R, Quereda C et al. Epidemiology of symptomatic hypotension in hemodialysis: is cool dialysate beneficial for all patients? Am J Nephrol 1990; 10: 177-180
23. Hiroshige K, Kabashima N, Takasugi M, Kuroiwa A. Optimal dialysis improves uremic pruritus. Am J Kidney Dis 1995; 25: 413-419
24. Henderson LW. Symptomatic hypotension during hemodialysis. Kidney Int 1980; 17: 571-576
25. Cheug AK, Chenoweth DE, Otsuka D, Henderson LW. Compartmental distribution of complement activation products in artificial kidneys. Kidney Int 1986; 30: 74-80
26. Maher ER, Wickens DG, Griffin JF, Kyle P, Curtis JR, Dormandy TL. Neutropenia and plasma free radical reaction products during haemodialysis. Nephrol Dial Transplant 1988; 3: 277-283
27. Collins DM, Lambert MB, Tannenbaum JS, Oliverio M, Schwab SJ. Tolerance of hemodialysis: a randomized prospective trial of high-flux versus conventionnal high-efficiency hemodialysis. J Am Soc Nephrol 1993; 4: 148-154
28. Bergamo Collaborative Dialysis Study Group. Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Kidney Int 1991; 40: 714-719